[DEPDC5, a new key to understand various epilepsies]

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Epilepsy is a frequent neurological disorder with recurrent seizures, often requiring lifelong treatment.
• Approximately 30% of epilepsy patients are refractory to current antiepileptic drugs, highlighting the need for novel therapies.
• Focal epilepsies, originating in one brain hemisphere, constitute about 60% of adult idiopathic epilepsy cases.

Purpose of the Study:

• To investigate the role of DEPDC5 gene mutations in focal epilepsy syndromes.
• To explore the molecular mechanisms underlying DEPDC5-related epileptogenesis.
• To identify DEPDC5 as a potential therapeutic target for epilepsy.

Main Methods:

• Genetic analysis of patients with focal epilepsy.
• Functional studies of DEPDC5 protein and its complex (GATOR1).
• Investigation of DEPDC5 function in neuronal systems using animal models.

Main Results:

• DEPDC5 mutations are frequently identified across a spectrum of focal epilepsy syndromes.
• DEPDC5 forms the GATOR1 complex with NPRL2 and NPRL3, inhibiting the mTORC1 pathway.
• DEPDC5's role in neuronal function is increasingly understood through recent animal model studies.

Conclusions:

• DEPDC5 is the most common causative gene identified in focal epilepsies to date.
• DEPDC5's unique mechanism, distinct from other epilepsy genes, offers new insights into epileptogenesis.
• Targeting DEPDC5 may lead to the development of versatile new therapies for various epilepsy types.